Objectives: Visual contrast detection thresholds and suprathreshold contrast discrimination thresholds were compared to luminance and ash/pattern electroretinograms (ERG) and visually evoked potentials (VEP) in patients with Parkinson's disease (n 31), patients with multiple system atrophy (n 6), patients with progressive supranuclear palsy (n 6) and control patients without central nervous disease (n 33).
Introduction
There is substantial evidence that Parkinson's disease is associated with visual impairments. These impairments are usually thought to be a result of an attenuation of the retinal signal at an early stage in the visual process. Electrophysiological evidence of visual pathology has been related to delays in visually evoked potentials (Bodis-Wollner and Yahr, 1978; Delwaide, 1980; Gawel, 1981; Marx et al., 1986) , as well as amplitude reductions in the pattern-electroretinogram (Ghilardi et al., 1989; Ikeda et al., 1994) . Psychophysically-de®ned contrast detection thresholds are also elevated in patients with Parkinson's disease (BodisWollner et al., 1987; Bodis-Wollner, 1990; Mestre et al., 1990 Mestre et al., , 1992 Masson et al., 1993) . The selective nature of the visual impairments (medium-to-high spatial frequencies and medium temporal frequencies; (Marx et al., 1986; Bodis-Wollner et al., 1987) ) suggests the involvement of speci®c mechanisms underlying the transfer of pattern contrast. The presence of normal pattern adaptation effects (Tebartz Van Elst et al., 1997) suggests that function in the visual cortex remains intact.
Dopamine is an important neurotransmitter in the visual pathway (Bodis-Wollner et al., 1987) . The presence of dopamine in the mammalian retina has been well documented (Haggendal and Malmfors, 1963; Dowling and Ehinger, 1975; Mariani et al., 1984; Massey and Redburn, 1987; Nguyen-Legros et al., 1988; Skrandies and Wa Èssle, 1988) , including the human retina (Frederick et al., 1982) . In addition to the loss of dopaminergic neurons in the pars compacta of the substantia nigra, Parkinson's disease has also been associated with a reduction in the level of dopamine in the retina (Harnois and Di Paolo, 1990) . There is
